Vimarsana
Biggest News Aggregation in the World

Page 9 - Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

Immunic, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Immunic, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update

– Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease Provide Proof-of-Concept for a New Therapeutic Approach to Treat Gastrointestinal...

Immunic : Q1 2023 News Release | MarketScreener - Vimarsana News

Immunic : Q1 2023 News Release | MarketScreener

Immunic, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update Positive Results From Phase 1b Clinical... | May 11, 2023

Immunic (IMUX) Set to Announce Quarterly Earnings on Thursday - Vimarsana News

Immunic (IMUX) Set to Announce Quarterly Earnings on Thursday

Immunic (NASDAQ:IMUX – Get Rating) is set to release its earnings data before the market opens on Thursday, May 11th. Analysts expect Immunic to post earnings of ($0.54) per share for the quarter. Immunic (NASDAQ:IMUX – Get Rating) last issued its earnings results on Thursday, February 23rd. The company reported ($1.63) earnings per share (EPS) […]

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2023, and Provide Corporate Update - Vimarsana News

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2023, and Provide Corporate Update

– Webcast to be Held at 8:00 am ET on May 11, 2023 – NEW YORK, May 9, 2023 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally... | May 9, 2023

EQS-News: Immunic, Inc.: Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action - Vimarsana News

EQS-News: Immunic, Inc.: Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

Issuer: Immunic, Inc. / Key word(s): Study/Conference Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action 06.05.2023